Adverse events160

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 160

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk
other	Blood uric acid increased	Investigations	DS-TB: Bedaquiline (Loading Dose/t.i.w)+ PA-824 + Pyrazinamide	15	59
other	Blood uric acid increased	Investigations	DS-TB: Bedaquiline (200 mg) + PA-824 + Pyrazinamide	13	60
other	Blood uric acid increased	Investigations	DS-TB: HRZE (Isoniazid+Rifampicin+Pyrazinamide+Ethambutol)	9	61
other	Blood uric acid increased	Investigations	MDR-TB: Bedaquiline (200 mg)+Moxifloxacin+PA-824+Pyrazinamide	27	60
other	Alanine aminotransferase increased	Investigations	DS-TB: Bedaquiline (Loading Dose/t.i.w)+ PA-824 + Pyrazinamide	3	59
other	Alanine aminotransferase increased	Investigations	DS-TB: Bedaquiline (200 mg) + PA-824 + Pyrazinamide	5	60
other	Alanine aminotransferase increased	Investigations	DS-TB: HRZE (Isoniazid+Rifampicin+Pyrazinamide+Ethambutol)	2	61
other	Alanine aminotransferase increased	Investigations	MDR-TB: Bedaquiline (200 mg)+Moxifloxacin+PA-824+Pyrazinamide	2	60
other	Aspartate aminotransferase increased	Investigations	DS-TB: Bedaquiline (Loading Dose/t.i.w)+ PA-824 + Pyrazinamide	3	59
other	Aspartate aminotransferase increased	Investigations	DS-TB: Bedaquiline (200 mg) + PA-824 + Pyrazinamide	3	60
other	Aspartate aminotransferase increased	Investigations	DS-TB: HRZE (Isoniazid+Rifampicin+Pyrazinamide+Ethambutol)	3	61
other	Aspartate aminotransferase increased	Investigations	MDR-TB: Bedaquiline (200 mg)+Moxifloxacin+PA-824+Pyrazinamide	3	60
other	Amylase increased	Investigations	DS-TB: Bedaquiline (Loading Dose/t.i.w)+ PA-824 + Pyrazinamide	0	59
other	Amylase increased	Investigations	DS-TB: Bedaquiline (200 mg) + PA-824 + Pyrazinamide	0	60
other	Amylase increased	Investigations	DS-TB: HRZE (Isoniazid+Rifampicin+Pyrazinamide+Ethambutol)	1	61
other	Amylase increased	Investigations	MDR-TB: Bedaquiline (200 mg)+Moxifloxacin+PA-824+Pyrazinamide	10	60
other	Gamma-glutamyltransferase increased	Investigations	DS-TB: Bedaquiline (Loading Dose/t.i.w)+ PA-824 + Pyrazinamide	0	59
other	Gamma-glutamyltransferase increased	Investigations	DS-TB: Bedaquiline (200 mg) + PA-824 + Pyrazinamide	2	60
other	Gamma-glutamyltransferase increased	Investigations	DS-TB: HRZE (Isoniazid+Rifampicin+Pyrazinamide+Ethambutol)	0	61
other	Gamma-glutamyltransferase increased	Investigations	MDR-TB: Bedaquiline (200 mg)+Moxifloxacin+PA-824+Pyrazinamide	6	60

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02193776/events

API reference For AI assistants

Adverse events160

Sources 3

Read this list from software.